Biotech IPOs Face New Challenges in 2025 and Beyond
After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only […]
After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only […]
TCG Labs Soleil, a company that creates focused biotechnology startups and prepares them for partnerships, announced on Thursday that it
The European Medicines Agency (EMA) has recommended against approving Sarepta’s gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) after a
In the world of drug development, business deals are just as important as scientific discoveries. Many of today’s top-selling medicines,
Proximie has teamed up with HistoSonics to bring the Edison Histotripsy System to more hospitals and surgical centers across the
Drug prices, especially those set when new medications first hit the market, are climbing higher and higher, according to the
Seaport Therapeutics has started its phase 2b BUOY-1 trial for GlyphAllo, a new oral medication for major depressive disorder (MDD),
The biotech world is going through a tough time right now. So far this year, big companies buying smaller ones
A recent study has found that a new type of medication may be effective in managing chronic pain. This new
A recently conducted study revealed that a new medication, known as Inclisiran, has shown promising results in lowering cholesterol levels.